Drug Profile
Laflunimus
Alternative Names: HR 325Latest Information Update: 10 Jun 1996
Price :
$50
*
At a glance
- Originator Aventis
- Class Antirheumatics; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 10 Jun 1996 Discontinued-II for Rheumatoid arthritis in France (Unknown route)
- 27 Apr 1995 Phase-II clinical trials for Rheumatoid arthritis in France (Unknown route)